`
`Newsroom Careers
`Contact Us
`
`Investor Relations
`
`Our Products
`
`Vision and Age
`
`Your Eye Concerns
`
`Our Company
`
`For Eye Care
`Professionals
`
`Text size A A+
`Search...
`
`Home Our Products Rx Pharmaceutical
`
`Rx Pharmaceutical
`
`Bausch + Lomb creates prescription drugs for a wide range of eye conditions. Your eye care professional will be able to prescribe or recommend the best Bausch +
`Lomb product for you.
`
`Alrex (loteprednol etabonate ophthalmic suspension) 0.2%
`Learn More
`
`BEPREVE (bepotastine besilate ophthalmic solution) 1.5%
`Learn More
`
`Besivance (besifloxacin ophthalmic suspension) 0.6%
`Learn More
`
`Istalol (timolol maleate ophthalmic solution) 0.5%
`Learn more
`
`LACRISERT (hydroxypropyl cellulose ophthalmic insert)
`Learn more
`
`Lotemax (loteprednol etabonate ophthalmic suspension 0.5%)
`Learn More
`
`Lotemax (loteprednol etabonate ophthalmic gel) 0.5%
`Learn More
`
`
`
`Lotemax (loteprednol etabonate ophthalmic ointment) 0.5%
`Learn More
`
`Macugen (pegaptanib sodium injection)
`Learn More
`
`PROLENSA (bromfenac ophthalmic solution) 0.07%
`Learn More
`
`Retisert (fluocinolone acetonide intravitreal implant)0.59 mg
`Learn More
`
`TIMOPTIC 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION) in OCUDOSE
`Learn More
`
`Visudyne (verteporfin for injection)
`Learn More
`
`Zirgan (ganciclovir ophthalmic gel) 0.15%
`Learn More
`
`Zylet (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension)
`Learn More
`
`US/LGX/12/0052(1)
`
`Vision and Eye Health
`
`Products
`
`Customer Support
`
`Legal
`
`Vision and Age
`Eye Infections & Irritations
`Diseases and Disorders
`Find a Doctor
`Eye Exam Check List
`
`Contact Lenses
`Contact Lens Care
`Dry Eye Products
`Allergy/Redness Relief
`Rx Pharmaceutical
`Eye Vitamins
`Surgical Products
`Vision Accessories
`
`Contact Us
`Customer policies and forms
`Rebate Center
`Worldwide Locations
`
`Legal Notice
`Privacy Policy
`Safety Data Sheets (SDS)
`
`© 2016 Bausch & Lomb Incorporated.
`
`All information and materials on this site pertain to the U.S. only, unless otherwise indicated.
`
`Newsroom
`Careers
`Investor Relations
`Grants & Contributions
`
`Page 2